World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
66
Citations
16815
World Ranking
2609
National Ranking
333

Overview

Tom Vulliamy is affiliated with Queen Mary University of London in the United Kingdom. Their research focuses primarily on medicine, with significant contributions to biochemistry, genetics, and molecular biology.

The scientist's work covers key subfields such as genetics, hematology, molecular biology, physiology, and immunology. Their research topics include acute myeloid leukemia research, blood disorders and treatments, myeloproliferative neoplasms diagnosis and treatment, telomeres, telomerase and senescence, immunodeficiency and autoimmune disorders, neonatal health and biochemistry, and oral and craniofacial lesions.

Frequent coauthors collaborating with Tom Vulliamy include:

  • Inderjeet Dokal
  • Hemanth Tummala
  • Amanda J. Walne
  • Jenna Alnajar
  • Findlay Bewicke-Copley

They have published in a range of scientific journals, with multiple works appearing in Blood, British Journal of Haematology, and The American Journal of Human Genetics. Other venues for publication include Nature Communications and Human Genetics.

Recent papers by Tom Vulliamy include:

  • The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants, 2020, Nature Communications
  • Inherited bone marrow failure in the pediatric patient, 2022, Blood
  • Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline, 2020, British Journal of Haematology
  • Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita, 2022, The American Journal of Human Genetics
  • High-throughput STELA provides a rapid test for the diagnosis of telomere biology disorders, 2021, Human Genetics

Best Publications

  • X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions

    Nina S. Heiss;Stuart W. Knight;Tom J. Vulliamy;Sabine M. Klauck

  • The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita

    Tom Vulliamy;Anna Marrone;Frederick Goldman;Andrew Dearlove

  • The Human Phenotype Ontology in 2017

    Sebastian Köhler;Nicole A. Vasilevsky;Mark Engelstad;Erin D. Foster

  • Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC

    Tom Vulliamy;Anna Marrone;Richard Szydlo;Amanda Walne

  • Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation.

    Tom J. Vulliamy;Tom J. Vulliamy;Tom J. Vulliamy;Anna Marrone;Anna Marrone;Anna Marrone;Stuart W. Knight;Stuart W. Knight;Stuart W. Knight;Amanda Walne;Amanda Walne;Amanda Walne

  • Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita

    Tom Vulliamy;Richard Beswick;Michael Kirwan;Anna Marrone

  • Hematologically important mutations: glucose-6-phosphate dehydrogenase.

    Ernest Beutler;Tom Vulliamy;Lucio Luzzatto

  • Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.

    Amanda J. Walne;Tom Vulliamy;Anna Marrone;Richard Beswick

  • Glucose-6-phosphate dehydrogenase deficiency

    Atul Mehta;Philip J. Mason;Tom J. Vulliamy

  • Inflammatory Skin and Bowel Disease Linked to ADAM17 Deletion

    Diana C. Blaydon;Paolo Biancheri;Wei Li Di;Vincent Plagnol

  • Association between aplastic anaemia and mutations in telomerase RNA

    Tom Vulliamy;Anna Marrone;Inderjeet Dokal;Philip J Mason

  • TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes

    Amanda J Walne;Thomas J Vulliamy;Richard Beswick;Michael Kirwan

  • Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5' non-coding region.

    M G Persico;G Viglietto;G Martini;D Toniolo

  • Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia

    T J Vulliamy;M D'Urso;G Battistuzzi;M Estrada

  • X-Linked Dyskeratosis Congenita Is Predominantly Caused by Missense Mutations in the DKC1 Gene

    S.W. Knight;N.S. Heiss;T.J. Vulliamy;S. Greschner

  • Constitutional mutations in RTEL1 cause severe dyskeratosis congenita.

    Amanda J. Walne;Tom Vulliamy;Michael Kirwan;Vincent Plagnol

  • Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase.

    G. Martini;D. Toniolo;T. Vulliamy;L. Luzzatto

  • Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.

    Tom J Vulliamy;Stuart W Knight;Philip J Mason;Inderjeet Dokal

  • Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal‐Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1

    S. W. Knight;N. S. Heiss;T. J. Vulliamy;C. M. Aalfs

  • Dyskeratosis Congenita (DC) Registry: identification of new features of DC.

    Stuart Knight;Tom Vulliamy;Adrian Copplestone;Eliane Gluckman

Frequent Co-Authors

Inderjeet Dokal
Inderjeet Dokal Queen Mary University of London
Philip J. Mason
Philip J. Mason Children's Hospital of Philadelphia
Lucio Luzzatto
Lucio Luzzatto University of Florence
Vincent Plagnol
Vincent Plagnol University College London
Jude Fitzgibbon
Jude Fitzgibbon Queen Mary University of London
Marek Sanak
Marek Sanak Jagiellonian University
John W. Holloway
John W. Holloway University of Southampton
David Price
David Price University of Aberdeen
Monica Bessler
Monica Bessler Children's Hospital of Philadelphia
Stephen J. Turner
Stephen J. Turner Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Genetics, several related online degrees and healthcare career pathways may also fit your interests and future goals. For students considering nursing, it’s important to know is the teas test required for all nursing programs. Some nursing schools offer admission without these standardized test requirements, providing flexible entry points for various applicants.

Those looking to advance their leadership in healthcare should explore online mha programs affordable to find master’s degrees that balance comprehensive curriculum with accessible tuition. Fast-tracked credentials, such as lpn fast track program options, help students quickly enter the workforce or transition between healthcare roles.

For those aiming at top-tier research or academic roles, earning a doctorate has never been more accessible with phd in nursing online programs. These online pathways open up new opportunities for advancement in both practice and research, aligning well with evolving careers in genetics and health sciences.

Best Scientists Citing Tom Vulliamy

Trending Scientists

Recently Published Articles